These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 32744679)

  • 1. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
    Li HL; Liang S; Cui JH; Han GY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7574. PubMed ID: 32744679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11464. PubMed ID: 33275204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Dong ZC; Zhang D; Wang SB; Lin ZQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10301. PubMed ID: 33155265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.
    Zhou QY; Peng PL; Xu YH
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7565. PubMed ID: 32744670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
    Wei RJ; Zhang CH; Yang WZ
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8239. PubMed ID: 32894521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
    Dong ZC; Zhang D; Zhang XX; Yao ZQ; Wu H; Chen CH; Tian JQ
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11990. PubMed ID: 33336717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
    Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7914. PubMed ID: 32767307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
    Li XD; Li XM; Gu JW; Sun XC
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7577. PubMed ID: 32744682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CASC15 promotes proliferation and induces apoptosis of cervical cancer cells through targeting miR-101-3p.
    Zhang YN; Liu B; Jiang T; Li Q
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8627. PubMed ID: 32965019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7.
    Zhang J; Gong WH; Li Y; Zhang HY; Zhang CX
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7568. PubMed ID: 32744673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-155 regulates the proliferation and apoptosis of pancreatic cancer cells through targeting SOCS3.
    Wang J; Guo J; Fan H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12625. PubMed ID: 33378006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.
    Wang DZ; Jing SF; Hao SB; Huang XY; Miao QT; Gao JF
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8242. PubMed ID: 32894525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-143 regulates proliferation and apoptosis of myelocytic leukemia cell HL-60 via modulating ERK1.
    Song B; Tang YJ; Zhang WG; Wan CC; Chen Y; Zhang LJ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9237. PubMed ID: 33015758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer.
    Huang K; Fan WS; Fu XY; Li YL; Meng YG
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7211. PubMed ID: 32706049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3.
    Cao HY; Xiao CH; Lu HJ; Yu HZ; Hong H; Guo CY; Yuan JF
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11468. PubMed ID: 33275208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
    Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7202. PubMed ID: 32706040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LINP1 promotes proliferation and inhibits apoptosis of gastric cancer cells by repressing RBM5.
    Lu XC; Zhou HY; Wu J; Jin Y; Yao XM; Wu XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7205. PubMed ID: 32706043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.
    Sun B; Ke KB; Liu DF; Wang Q; Li YN; Chen JH; Zhang JH
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10919. PubMed ID: 33215403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
    You Q; Shi HY; Gong CF; Tian XY; Li S
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(16):8243. PubMed ID: 32894524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
    Wang L; Xu T; Cui X; Han M; Zhou LH; Wei ZX; Xu ZJ; Jiang Y
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7917. PubMed ID: 32767310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.